Pharmstandard International
investment firm
About
Pharmstandard International
Highlights
Details
- Operating Status
- Active
Investments
Number of Investments
Number of Lead Investments
3
2
Pharmstandard International has made 3 investments. Their most recent investment was on
Dec 11, 2017, when OncoTartis raised $6M.
|
Date
Company Name
|
Round | Money Raised | Industry | Lead Investor |
|---|---|---|---|---|
|
Dec 11, 2017
|
Series Unknown | $6M | Biometrics | Yes |
|
Jul 16, 2015
Protagonist Therapeutics
|
Series C | $40M | Biotechnology | — |
|
Nov 20, 2013
Argos Therapeutics
|
Series E | $17.50M | Biotechnology | Yes |
Exits
Pharmstandard International has had 2 exits. Pharmstandard International most notable exits include Argos Therapeutics , Protagonist Therapeutics
| Date | Company Name | Exit Type | Industry | |
|---|---|---|---|---|
| Apr 23, 2018 | Argos Therapeutics | M&A | Biotechnology | Detail |
| Aug 10, 2016 | Protagonist Therapeutics | IPO | Biotechnology | Detail |
Share
Twitter
LinkedIn
Line
Facebook
Telegram
Email
Page Link
